RA0184

antibody from Oursmab

Targeting: DLL3 SCDO1

Western blot (Supportive data in Antibodypedia)

ELISA (Data presented on provider website)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0184

Provider

Oursmab

Product name

Rovalpituzumab (Biosimilar Reference Antibody) (DLL3)

Antibody type

Monoclonal

Description

Rovalpituzumab is an antibody-drug conjugate (ADC) targeting delta-like protein 3 (DLL3), a Notch ligand family member highly expressed on the surface of small cell lung cancer (SCLC) and other neuroendocrine tumors. It delivers a cytotoxic payload (typically a DNA-damaging agent) directly to DLL3-positive cancer cells, inducing cell death.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Rovalpituzumab (Biosimilar Reference Antibody) (DLL3)-RA0184-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.